Evidence map›Paper›PMID 40454743›Full record

ArticleMedical physics2025

Characterizing diamond detectors for various dose and dose rate measurements in scanned carbon and oxygen beams.

Celine Karle, Gianluca Verona-Rinati, Stephan Brons, Rainer Cee, Stefan Scheloske, Christian Schömers, Rafael Kranzer, Thomas Haberer, Marco Marinelli, Andrea Mairani and 1 more

Abstract read
In one paragraph

Article in Medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Celine KarleClinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Gianluca Verona-RinatiIndustrial Engineering Department, University of Rome "Tor Vergata", Rome, Italy.
Stephan BronsHeidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Rainer CeeHeidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Stefan ScheloskeHeidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Christian SchömersHeidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Rafael KranzerPTW-Freiburg, Freiburg, Germany.
Thomas HabererHeidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Marco MarinelliIndustrial Engineering Department, University of Rome "Tor Vergata", Rome, Italy.
Andrea MairaniClinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Thomas TessonnierHeidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.

Funding

Translational Studies in FLASH Particle RadiotherapyP01CA257904 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Mary E. Putt · 2022 to 2026
$14.2M
German Research Council DFG-Unite: SFB1389/2C05National Center for Tumor DiseasesNCI NIH HHS P01 CA257904NIH-P01CA257904
6 · The paper itself

Abstract

backgroundThe emerging FLASH radiotherapy technique employs "Ultra-High Dose Rate" (UHDR) irradiations and offers the potential to spare normal tissue while maintaining iso-effective tumor treatment. Given the physical and biological advantages inherent to high "Linear Energy Transfer" (LET) particles, the combination of UHDR and high LET has the capability to enhance the normal tissues sparing, as indicated by initial in vivo trials. However, to ensure a safe implementation of this combined modality, it is essential to establish robust dosimetric protocols utilizing dose-, dose rate-, and LET-independent detectors. PURPOSE: The objective of this study is to characterize the dose, dose rate, and LET dependency of two diamond detectors with high LET carbon and oxygen ion irradiation under "Standard Dose Rate" (SDR) and UHDR conditions.

methodsThe "microDiamond" (mD) and a "flashDiamond" (fD) prototype were benchmarked against measurements with a monitoring ionization chamber, Advanced Markus chamber (AMC), and simulations for carbon and oxygen irradiation, with energies of 274.98 MeV/u and 325.98 MeV/u under SDR and UHDR conditions. First, the entire depth-dose profiles obtained during SDR irradiations and the partial in-depth profiles of the Bragg peak region in UHDR were compared to the corresponding simulation values. Secondly, the linearity of the diamond detector response during dose escalation measurements was investigated for both dose rates.

resultsThe two detectors exhibited alignment with the simulated depth-dose distributions for oxygen and carbon irradiations across both dose rate conditions. The mD overestimated the dose values for carbon and oxygen measurements. This overestimation increased with "dose-averaged LET" (LETd) during SDR irradiation and maintained a stable value of 5% for UHDR. Meanwhile, the fD demonstrated a high degree of agreement with the simulation, with a maximum discrepancy of 5% across all irradiation modalities in the plateau and "Bragg Peak" (BP). Deviations were observed in the BP fall-off region, while both diamond detectors exhibited a strong alignment with the AMC measurements. Furthermore, both detectors exhibited dose linearity under SDR and UHDR irradiation for both carbon and oxygen irradiation, with a coefficient of determination (R

conclusionIn the context of heavy ion carbon and oxygen irradiation in UHDR and SDR, the two diamond detectors demonstrated dose-rate independence. While the mD exhibited a tendency to overestimate dose values with increasing LETd, the fD was found to be LET-independent. The fD appears to offer accurate and reliable dose assessments for UHDR heavy ion experiments.

Indexed as

CarbonDiamondOxygenRadiation DosageRadiometryLinear Energy TransferRadiotherapy DosageCarbonDiamondOxygendiamond detectorhigh LETUHDR

Identifiers

PMID40454743
PMCPMC12257998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.